Laboratorios SALVAT SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Laboratorios SALVAT SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013999
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorios SALVAT SA (SALVAT) is a manufacturer of pharmaceutical products for healthcare industries. The company offers prescription and over-the- counter drugs in various segments such as personal healthcare, metabolism, urology, ophtholmology, dermatology and malaria. Its personal healthcare product portfolio includes bester complex, magnesium pyre, protransitus, nutira, urosens, levogastrol, salvarina, neomicina, and vincigrip among others. SALVAT’s metabolism segment offers fisiobil, meteoril and nutira, and others. The company’s activities also include blow-fill-seal contract manufacturing of small fill volume pharmaceutical unit dose sterile liquids such as ear drops and eye drops. It operates through a network of distributors in Europe, America, Asia and Africa, and the Middle East. SALVAT is headquartered in Barcelona, Spain.

Laboratorios SALVAT SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 10
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 11
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 12
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 13
Laboratorios SALVAT Enters Into Licensing Agreement With Hyphens Pharma For CETRAXAL 14
Luqa Enters Into Licensing Agreement With Salvat For Cetraxal Plus 15
Salvat Enters Into Licensing Agreement With Luqa Ventures For Ebernet 16
Equity Offering 17
Loop Therapeutics Spin Off from Laboratorios SALVAT 17
Laboratorios SALVAT SA – Key Competitors 18
Laboratorios SALVAT SA – Key Employees 19
Laboratorios SALVAT SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratorios SALVAT SA, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 10
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 11
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 12
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 13
Laboratorios SALVAT Enters Into Licensing Agreement With Hyphens Pharma For CETRAXAL 14
Luqa Enters Into Licensing Agreement With Salvat For Cetraxal Plus 15
Salvat Enters Into Licensing Agreement With Luqa Ventures For Ebernet 16
Loop Therapeutics Spin Off from Laboratorios SALVAT 17
Laboratorios SALVAT SA, Key Competitors 18
Laboratorios SALVAT SA, Key Employees 19
Laboratorios SALVAT SA, Subsidiaries 20

★海外企業調査レポート[Laboratorios SALVAT SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Insmed Inc (INSM):医療機器:M&Aディール及び事業提携情報
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline are bein …
  • Syros Pharmaceuticals Inc (SYRS):医療機器:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Tootsie Roll Industries, Inc.:企業の戦略・SWOT・財務情報
    Tootsie Roll Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tootsie Roll Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Plantic Technologies Ltd:企業の戦略的SWOT分析
    Plantic Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Jiangsu Jumpcan Pharmaceutical Group Co Ltd (600566):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Jumpcan Pharmaceutical Group Co Ltd (Jiangsu Jumpcan Pharma) is a developer, manufacturer and distributor of Chinese traditional medicine, Western medicine, daily use chemicals and healthcare products. The company offers its products in various therapeutic segments such as detoxifica …
  • Safran SA:企業の戦略・SWOT・財務情報
    Safran SA - Strategy, SWOT and Corporate Finance Report Summary Safran SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Hitachi Chemical Co Ltd (4217):企業の財務・戦略的SWOT分析
    Hitachi Chemical Co Ltd (4217) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Apollo Hospitals Enterprise Ltd (APOLLOHOSP):製薬・医療:M&Aディール及び事業提携情報
    Summary Apollo Hospitals Enterprise Ltd (Apollo Hospitals) is a healthcare service provider. It offers healthcare services, clinical and diagnostic services, medical business process outsourcing, third party administration services and health insurance. The company also provides services to support …
  • Centre for Commercialization of Regenerative Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is a healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, biomaterials and devices manufacturing, and protocol development services. The center harnesses the power of stem cells, biomateri …
  • Integrated Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company’s tools assist physicians in the early diagnosis of complex diseases with a non-invasive blood test, such as lung cancer …
  • Tokuyama Corp (4043):電力:M&Aディール及び事業提携情報
    Summary Tokuyama Corp (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene …
  • Luna Innovations Inc (LUNA):企業の製品パイプライン分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • International Dairy Queen, Inc.:企業の戦略的SWOT分析
    International Dairy Queen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • NeoTract Inc:医療機器:M&Aディール及び事業提携情報
    Summary NeoTract Inc (NeoTract) is a medical device company that designs and develops minimally invasive devices for use in the field of urology. The company’s urolift system is designed to treat lower urinary tract symptoms caused by benign prostatic hyperplasia. It partners with its customers to i …
  • Greenfields Petroleum Corp (GNF):石油・ガス:M&Aディール及び事業提携情報
    Summary Greenfields Petroleum Corp (Greenfields) is an oil and natural gas company that develops and produces proven oil and gas reserves. The company acquires, develops, and produces oil and gas deposits by developing international projects. It holds interest in the Bahar Project which consists of …
  • Black & Veatch Holding Company:企業の戦略・SWOT・財務分析
    Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report Summary Black & Veatch Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • EGYPTAIR Holding Company:企業の戦略・SWOT・財務分析
    EGYPTAIR Holding Company - Strategy, SWOT and Corporate Finance Report Summary EGYPTAIR Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • DTE Energy Co (DTE)-エネルギー分野:企業M&A・提携分析
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • A. Menarini Industrie Farmaceutiche Riunite Srl:企業の戦略的SWOT分析
    A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Rada Electronic Industries Ltd.
    Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆